Combating antimicrobial resistance and protecting the miracle of modern medicine /:
Antimicrobial resistance is a health problem that threatens to undermine almost a century of medical progress. Moreover, it is a global problem that requires action both in the United States and internationally. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine discuss...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, DC :
National Academies Press,
[2022]
|
| Schriftenreihe: | Consensus study report.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | Antimicrobial resistance is a health problem that threatens to undermine almost a century of medical progress. Moreover, it is a global problem that requires action both in the United States and internationally. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine discusses ways to improve detection of resistant infections in the United States and abroad, including monitoring environmental reservoirs of resistance. This report sets out a strategy for improving stewardship and preventing infections in humans and animals. The report also discusses the strength of the pipeline for new antimicrobial medicines and steps that could be taken to bring a range of preventive and therapeutic products for humans and animals to the market. |
| Beschreibung: | 1 online resource (1 PDF file (xxviii, 365 pages)) : illustrations. |
| Bibliographie: | Includes bibliographical references. |
| ISBN: | 0309269474 9780309269476 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1296428759 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 220302s2022 dcua ob 000 0 eng | ||
| 010 | |a 2021949602 | ||
| 040 | |a NLM |b eng |e rda |c NLM |d YDX |d EBLCP |d OCLCO |d OCLCF |d N$T |d S1C |d OCLCO |d UKAHL |d TMA |d OCLCQ | ||
| 016 | 7 | |a 9918366141406676 |2 DNLM | |
| 019 | |a 1295212304 |a 1295214934 |a 1295243851 | ||
| 020 | |a 0309269474 | ||
| 020 | |a 9780309269476 |q (electronic bk.) | ||
| 020 | |z 9780309269452 | ||
| 020 | |z 0309269458 | ||
| 035 | |a (OCoLC)1296428759 |z (OCoLC)1295212304 |z (OCoLC)1295214934 |z (OCoLC)1295243851 | ||
| 042 | |a pcc | ||
| 050 | 4 | |a QR177 | |
| 060 | 0 | 0 | |a QW 45 |
| 082 | 7 | |a 616.9041 |2 23/eng/20230106 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Combating antimicrobial resistance and protecting the miracle of modern medicine / |c Guy H. Palmer, Gillian J. Buckley, editors ; Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States, Board on Population Health and Public Health Practice, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine. |
| 264 | 1 | |a Washington, DC : |b National Academies Press, |c [2022] | |
| 300 | |a 1 online resource (1 PDF file (xxviii, 365 pages)) : |b illustrations. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Consensus study report of the National Academies of Sciences, Engineering, Medicine | |
| 504 | |a Includes bibliographical references. | ||
| 520 | 3 | |a Antimicrobial resistance is a health problem that threatens to undermine almost a century of medical progress. Moreover, it is a global problem that requires action both in the United States and internationally. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine discusses ways to improve detection of resistant infections in the United States and abroad, including monitoring environmental reservoirs of resistance. This report sets out a strategy for improving stewardship and preventing infections in humans and animals. The report also discusses the strength of the pipeline for new antimicrobial medicines and steps that could be taken to bring a range of preventive and therapeutic products for humans and animals to the market. | |
| 536 | |a This project has been funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN263201800029I, Task Order No. 75N98020F00003. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project. | ||
| 588 | |a Description based on online resource; title from PDF title page (viewed April 20, 2022). | ||
| 505 | 0 | 0 | |g Intro -- |g FrontMatter -- |g Reviewers -- |g Preface -- |g Acknowledgments -- |g Contents -- |g Boxes, Figures, and Tables -- |g Acronyms and Abbreviations -- |g Summary -- |g 1 |t Introduction -- |g 2 |t The Scope of the Problem -- |g 3 |t The Health and Economic Burden of Resistance -- |g 4 |t Strengthening Surveillance -- |g 5 |t Stewardship and Infection Prevention -- |g 6 |t Bringing New Products to Market and Ensuring Their Reach -- |g 7 |t The National Action Plan for Combating Antibiotic-Resistant Bacteria -- |g 8 |t A Role for the United States in Coordinated Global Action -- |g Appendix A: |t Committee Member Biographies |
| 505 | 8 | 0 | |g Appendix B: |t Disclosure of Unavoidable Conflict of Interest -- |g Appendix C: |t Open Session Agendas |
| 650 | 0 | |a Drug resistance in microorganisms. |0 http://id.loc.gov/authorities/subjects/sh85039709 | |
| 650 | 0 | |a Anti-infective agents. |0 http://id.loc.gov/authorities/subjects/sh85005613 | |
| 650 | 0 | |a Environmental monitoring. |0 http://id.loc.gov/authorities/subjects/sh85044194 | |
| 650 | 1 | 2 | |a Drug Resistance, Microbial |0 https://id.nlm.nih.gov/mesh/D004352 |
| 650 | 1 | 2 | |a Drug Resistance, Bacterial |0 https://id.nlm.nih.gov/mesh/D024881 |
| 650 | 2 | 2 | |a Anti-Infective Agents |0 https://id.nlm.nih.gov/mesh/D000890 |
| 650 | 2 | 2 | |a Anti-Bacterial Agents |0 https://id.nlm.nih.gov/mesh/D000900 |
| 650 | 2 | 2 | |a Antimicrobial Stewardship |0 https://id.nlm.nih.gov/mesh/D000073602 |
| 650 | 2 | 2 | |a Environmental Monitoring |0 https://id.nlm.nih.gov/mesh/D004784 |
| 651 | 2 | |a United States |0 https://id.nlm.nih.gov/mesh/D014481 | |
| 650 | 6 | |a Micro-organismes |x Résistance aux médicaments. | |
| 650 | 6 | |a Bactéries pathogènes |x Résistance aux médicaments. | |
| 650 | 6 | |a Antiinfectieux. | |
| 650 | 6 | |a Environnement |x Surveillance. | |
| 650 | 7 | |a Anti-infective agents |2 fast | |
| 650 | 7 | |a Drug resistance in microorganisms |2 fast | |
| 650 | 7 | |a Environmental monitoring |2 fast | |
| 700 | 1 | |a Buckley, Gillian J., |e editor. |0 http://id.loc.gov/authorities/names/no2012106161 | |
| 700 | 1 | |a Palmer, Guy |q (Guy Hughes), |d 1955- |e editor. |0 http://id.loc.gov/authorities/names/no2006124239 | |
| 710 | 2 | |a National Academies of Sciences, Engineering, and Medicine (U.S.). |b Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States, |e issuing body. |0 http://id.loc.gov/authorities/names/n2022181477 | |
| 776 | 0 | 8 | |i Print version: |a National Academies of Sciences, Engineering, and Medicine |t Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine |d Washington, D.C. : National Academies Press,c2022 |z 9780309269452 |
| 830 | 0 | |a Consensus study report. |0 http://id.loc.gov/authorities/names/n2017188206 | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3165662 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH41716195 | ||
| 938 | |a YBP Library Services |b YANK |n 302707208 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL6882178 | ||
| 938 | |a EBSCOhost |b EBSC |n 3165662 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1296428759 |
|---|---|
| _version_ | 1816882556250882048 |
| adam_text | |
| any_adam_object | |
| author2 | Buckley, Gillian J. Palmer, Guy (Guy Hughes), 1955- |
| author2_role | edt edt |
| author2_variant | g j b gj gjb g p gp |
| author_GND | http://id.loc.gov/authorities/names/no2012106161 http://id.loc.gov/authorities/names/no2006124239 |
| author_facet | Buckley, Gillian J. Palmer, Guy (Guy Hughes), 1955- |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | Q - Science |
| callnumber-label | QR177 |
| callnumber-raw | QR177 |
| callnumber-search | QR177 |
| callnumber-sort | QR 3177 |
| callnumber-subject | QR - Microbiology |
| collection | ZDB-4-EBA |
| contents | Introduction -- The Scope of the Problem -- The Health and Economic Burden of Resistance -- Strengthening Surveillance -- Stewardship and Infection Prevention -- Bringing New Products to Market and Ensuring Their Reach -- The National Action Plan for Combating Antibiotic-Resistant Bacteria -- A Role for the United States in Coordinated Global Action -- Committee Member Biographies Disclosure of Unavoidable Conflict of Interest -- Open Session Agendas |
| ctrlnum | (OCoLC)1296428759 |
| dewey-full | 616.9041 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.9041 |
| dewey-search | 616.9041 |
| dewey-sort | 3616.9041 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05999cam a2200757 i 4500</leader><controlfield tag="001">ZDB-4-EBA-on1296428759</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">220302s2022 dcua ob 000 0 eng </controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2021949602</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NLM</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NLM</subfield><subfield code="d">YDX</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCF</subfield><subfield code="d">N$T</subfield><subfield code="d">S1C</subfield><subfield code="d">OCLCO</subfield><subfield code="d">UKAHL</subfield><subfield code="d">TMA</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">9918366141406676</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">1295212304</subfield><subfield code="a">1295214934</subfield><subfield code="a">1295243851</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309269474</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309269476</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309269452</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309269458</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1296428759</subfield><subfield code="z">(OCoLC)1295212304</subfield><subfield code="z">(OCoLC)1295214934</subfield><subfield code="z">(OCoLC)1295243851</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">pcc</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QR177</subfield></datafield><datafield tag="060" ind1="0" ind2="0"><subfield code="a">QW 45</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.9041</subfield><subfield code="2">23/eng/20230106</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Combating antimicrobial resistance and protecting the miracle of modern medicine /</subfield><subfield code="c">Guy H. Palmer, Gillian J. Buckley, editors ; Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States, Board on Population Health and Public Health Practice, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, DC :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">[2022]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (1 PDF file (xxviii, 365 pages)) :</subfield><subfield code="b">illustrations.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Consensus study report of the National Academies of Sciences, Engineering, Medicine</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Antimicrobial resistance is a health problem that threatens to undermine almost a century of medical progress. Moreover, it is a global problem that requires action both in the United States and internationally. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine discusses ways to improve detection of resistant infections in the United States and abroad, including monitoring environmental reservoirs of resistance. This report sets out a strategy for improving stewardship and preventing infections in humans and animals. The report also discusses the strength of the pipeline for new antimicrobial medicines and steps that could be taken to bring a range of preventive and therapeutic products for humans and animals to the market.</subfield></datafield><datafield tag="536" ind1=" " ind2=" "><subfield code="a">This project has been funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN263201800029I, Task Order No. 75N98020F00003. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (viewed April 20, 2022).</subfield></datafield><datafield tag="505" ind1="0" ind2="0"><subfield code="g">Intro --</subfield><subfield code="g">FrontMatter --</subfield><subfield code="g">Reviewers --</subfield><subfield code="g">Preface --</subfield><subfield code="g">Acknowledgments --</subfield><subfield code="g">Contents --</subfield><subfield code="g">Boxes, Figures, and Tables --</subfield><subfield code="g">Acronyms and Abbreviations --</subfield><subfield code="g">Summary --</subfield><subfield code="g">1</subfield><subfield code="t">Introduction --</subfield><subfield code="g">2</subfield><subfield code="t">The Scope of the Problem --</subfield><subfield code="g">3</subfield><subfield code="t">The Health and Economic Burden of Resistance --</subfield><subfield code="g">4</subfield><subfield code="t">Strengthening Surveillance --</subfield><subfield code="g">5</subfield><subfield code="t">Stewardship and Infection Prevention --</subfield><subfield code="g">6</subfield><subfield code="t">Bringing New Products to Market and Ensuring Their Reach --</subfield><subfield code="g">7</subfield><subfield code="t">The National Action Plan for Combating Antibiotic-Resistant Bacteria --</subfield><subfield code="g">8</subfield><subfield code="t">A Role for the United States in Coordinated Global Action --</subfield><subfield code="g">Appendix A:</subfield><subfield code="t">Committee Member Biographies</subfield></datafield><datafield tag="505" ind1="8" ind2="0"><subfield code="g">Appendix B:</subfield><subfield code="t">Disclosure of Unavoidable Conflict of Interest --</subfield><subfield code="g">Appendix C:</subfield><subfield code="t">Open Session Agendas</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug resistance in microorganisms.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85039709</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Anti-infective agents.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85005613</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Environmental monitoring.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85044194</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Drug Resistance, Microbial</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D004352</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Drug Resistance, Bacterial</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D024881</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Anti-Infective Agents</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D000890</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Anti-Bacterial Agents</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D000900</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Antimicrobial Stewardship</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D000073602</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Environmental Monitoring</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D004784</subfield></datafield><datafield tag="651" ind1=" " ind2="2"><subfield code="a">United States</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D014481</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Micro-organismes</subfield><subfield code="x">Résistance aux médicaments.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Bactéries pathogènes</subfield><subfield code="x">Résistance aux médicaments.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Antiinfectieux.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Environnement</subfield><subfield code="x">Surveillance.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anti-infective agents</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug resistance in microorganisms</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Environmental monitoring</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buckley, Gillian J.,</subfield><subfield code="e">editor.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2012106161</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Palmer, Guy</subfield><subfield code="q">(Guy Hughes),</subfield><subfield code="d">1955-</subfield><subfield code="e">editor.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2006124239</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Academies of Sciences, Engineering, and Medicine (U.S.).</subfield><subfield code="b">Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States,</subfield><subfield code="e">issuing body.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2022181477</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">National Academies of Sciences, Engineering, and Medicine</subfield><subfield code="t">Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine</subfield><subfield code="d">Washington, D.C. : National Academies Press,c2022</subfield><subfield code="z">9780309269452</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Consensus study report.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2017188206</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3165662</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH41716195</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">302707208</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL6882178</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">3165662</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| geographic | United States https://id.nlm.nih.gov/mesh/D014481 |
| geographic_facet | United States |
| id | ZDB-4-EBA-on1296428759 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:30:29Z |
| institution | BVB |
| institution_GND | http://id.loc.gov/authorities/names/n2022181477 |
| isbn | 0309269474 9780309269476 |
| language | English |
| lccn | 2021949602 |
| oclc_num | 1296428759 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (1 PDF file (xxviii, 365 pages)) : illustrations. |
| psigel | ZDB-4-EBA |
| publishDate | 2022 |
| publishDateSearch | 2022 |
| publishDateSort | 2022 |
| publisher | National Academies Press, |
| record_format | marc |
| series | Consensus study report. |
| series2 | Consensus study report of the National Academies of Sciences, Engineering, Medicine |
| spelling | Combating antimicrobial resistance and protecting the miracle of modern medicine / Guy H. Palmer, Gillian J. Buckley, editors ; Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States, Board on Population Health and Public Health Practice, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine. Washington, DC : National Academies Press, [2022] 1 online resource (1 PDF file (xxviii, 365 pages)) : illustrations. text txt rdacontent computer c rdamedia online resource cr rdacarrier Consensus study report of the National Academies of Sciences, Engineering, Medicine Includes bibliographical references. Antimicrobial resistance is a health problem that threatens to undermine almost a century of medical progress. Moreover, it is a global problem that requires action both in the United States and internationally. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine discusses ways to improve detection of resistant infections in the United States and abroad, including monitoring environmental reservoirs of resistance. This report sets out a strategy for improving stewardship and preventing infections in humans and animals. The report also discusses the strength of the pipeline for new antimicrobial medicines and steps that could be taken to bring a range of preventive and therapeutic products for humans and animals to the market. This project has been funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN263201800029I, Task Order No. 75N98020F00003. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project. Description based on online resource; title from PDF title page (viewed April 20, 2022). Intro -- FrontMatter -- Reviewers -- Preface -- Acknowledgments -- Contents -- Boxes, Figures, and Tables -- Acronyms and Abbreviations -- Summary -- 1 Introduction -- 2 The Scope of the Problem -- 3 The Health and Economic Burden of Resistance -- 4 Strengthening Surveillance -- 5 Stewardship and Infection Prevention -- 6 Bringing New Products to Market and Ensuring Their Reach -- 7 The National Action Plan for Combating Antibiotic-Resistant Bacteria -- 8 A Role for the United States in Coordinated Global Action -- Appendix A: Committee Member Biographies Appendix B: Disclosure of Unavoidable Conflict of Interest -- Appendix C: Open Session Agendas Drug resistance in microorganisms. http://id.loc.gov/authorities/subjects/sh85039709 Anti-infective agents. http://id.loc.gov/authorities/subjects/sh85005613 Environmental monitoring. http://id.loc.gov/authorities/subjects/sh85044194 Drug Resistance, Microbial https://id.nlm.nih.gov/mesh/D004352 Drug Resistance, Bacterial https://id.nlm.nih.gov/mesh/D024881 Anti-Infective Agents https://id.nlm.nih.gov/mesh/D000890 Anti-Bacterial Agents https://id.nlm.nih.gov/mesh/D000900 Antimicrobial Stewardship https://id.nlm.nih.gov/mesh/D000073602 Environmental Monitoring https://id.nlm.nih.gov/mesh/D004784 United States https://id.nlm.nih.gov/mesh/D014481 Micro-organismes Résistance aux médicaments. Bactéries pathogènes Résistance aux médicaments. Antiinfectieux. Environnement Surveillance. Anti-infective agents fast Drug resistance in microorganisms fast Environmental monitoring fast Buckley, Gillian J., editor. http://id.loc.gov/authorities/names/no2012106161 Palmer, Guy (Guy Hughes), 1955- editor. http://id.loc.gov/authorities/names/no2006124239 National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States, issuing body. http://id.loc.gov/authorities/names/n2022181477 Print version: National Academies of Sciences, Engineering, and Medicine Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine Washington, D.C. : National Academies Press,c2022 9780309269452 Consensus study report. http://id.loc.gov/authorities/names/n2017188206 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3165662 Volltext |
| spellingShingle | Combating antimicrobial resistance and protecting the miracle of modern medicine / Consensus study report. Introduction -- The Scope of the Problem -- The Health and Economic Burden of Resistance -- Strengthening Surveillance -- Stewardship and Infection Prevention -- Bringing New Products to Market and Ensuring Their Reach -- The National Action Plan for Combating Antibiotic-Resistant Bacteria -- A Role for the United States in Coordinated Global Action -- Committee Member Biographies Disclosure of Unavoidable Conflict of Interest -- Open Session Agendas Drug resistance in microorganisms. http://id.loc.gov/authorities/subjects/sh85039709 Anti-infective agents. http://id.loc.gov/authorities/subjects/sh85005613 Environmental monitoring. http://id.loc.gov/authorities/subjects/sh85044194 Drug Resistance, Microbial https://id.nlm.nih.gov/mesh/D004352 Drug Resistance, Bacterial https://id.nlm.nih.gov/mesh/D024881 Anti-Infective Agents https://id.nlm.nih.gov/mesh/D000890 Anti-Bacterial Agents https://id.nlm.nih.gov/mesh/D000900 Antimicrobial Stewardship https://id.nlm.nih.gov/mesh/D000073602 Environmental Monitoring https://id.nlm.nih.gov/mesh/D004784 Micro-organismes Résistance aux médicaments. Bactéries pathogènes Résistance aux médicaments. Antiinfectieux. Environnement Surveillance. Anti-infective agents fast Drug resistance in microorganisms fast Environmental monitoring fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85039709 http://id.loc.gov/authorities/subjects/sh85005613 http://id.loc.gov/authorities/subjects/sh85044194 https://id.nlm.nih.gov/mesh/D004352 https://id.nlm.nih.gov/mesh/D024881 https://id.nlm.nih.gov/mesh/D000890 https://id.nlm.nih.gov/mesh/D000900 https://id.nlm.nih.gov/mesh/D000073602 https://id.nlm.nih.gov/mesh/D004784 https://id.nlm.nih.gov/mesh/D014481 |
| title | Combating antimicrobial resistance and protecting the miracle of modern medicine / |
| title_alt | Introduction -- The Scope of the Problem -- The Health and Economic Burden of Resistance -- Strengthening Surveillance -- Stewardship and Infection Prevention -- Bringing New Products to Market and Ensuring Their Reach -- The National Action Plan for Combating Antibiotic-Resistant Bacteria -- A Role for the United States in Coordinated Global Action -- Committee Member Biographies Disclosure of Unavoidable Conflict of Interest -- Open Session Agendas |
| title_auth | Combating antimicrobial resistance and protecting the miracle of modern medicine / |
| title_exact_search | Combating antimicrobial resistance and protecting the miracle of modern medicine / |
| title_full | Combating antimicrobial resistance and protecting the miracle of modern medicine / Guy H. Palmer, Gillian J. Buckley, editors ; Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States, Board on Population Health and Public Health Practice, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine. |
| title_fullStr | Combating antimicrobial resistance and protecting the miracle of modern medicine / Guy H. Palmer, Gillian J. Buckley, editors ; Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States, Board on Population Health and Public Health Practice, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine. |
| title_full_unstemmed | Combating antimicrobial resistance and protecting the miracle of modern medicine / Guy H. Palmer, Gillian J. Buckley, editors ; Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States, Board on Population Health and Public Health Practice, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine. |
| title_short | Combating antimicrobial resistance and protecting the miracle of modern medicine / |
| title_sort | combating antimicrobial resistance and protecting the miracle of modern medicine |
| topic | Drug resistance in microorganisms. http://id.loc.gov/authorities/subjects/sh85039709 Anti-infective agents. http://id.loc.gov/authorities/subjects/sh85005613 Environmental monitoring. http://id.loc.gov/authorities/subjects/sh85044194 Drug Resistance, Microbial https://id.nlm.nih.gov/mesh/D004352 Drug Resistance, Bacterial https://id.nlm.nih.gov/mesh/D024881 Anti-Infective Agents https://id.nlm.nih.gov/mesh/D000890 Anti-Bacterial Agents https://id.nlm.nih.gov/mesh/D000900 Antimicrobial Stewardship https://id.nlm.nih.gov/mesh/D000073602 Environmental Monitoring https://id.nlm.nih.gov/mesh/D004784 Micro-organismes Résistance aux médicaments. Bactéries pathogènes Résistance aux médicaments. Antiinfectieux. Environnement Surveillance. Anti-infective agents fast Drug resistance in microorganisms fast Environmental monitoring fast |
| topic_facet | Drug resistance in microorganisms. Anti-infective agents. Environmental monitoring. Drug Resistance, Microbial Drug Resistance, Bacterial Anti-Infective Agents Anti-Bacterial Agents Antimicrobial Stewardship Environmental Monitoring United States Micro-organismes Résistance aux médicaments. Bactéries pathogènes Résistance aux médicaments. Antiinfectieux. Environnement Surveillance. Anti-infective agents Drug resistance in microorganisms Environmental monitoring |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3165662 |
| work_keys_str_mv | AT buckleygillianj combatingantimicrobialresistanceandprotectingthemiracleofmodernmedicine AT palmerguy combatingantimicrobialresistanceandprotectingthemiracleofmodernmedicine AT nationalacademiesofsciencesengineeringandmedicineuscommitteeonthelongtermhealthandeconomiceffectsofantimicrobialresistanceintheunitedstates combatingantimicrobialresistanceandprotectingthemiracleofmodernmedicine |